Literature DB >> 7362233

Metabolism of all-trans-retinoic acid in hamster liver microsomes: oxidation of 4-hydroxy- to 4-keto-retinoic acid.

A B Roberts, L C Lamb, M B Sporn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7362233     DOI： 10.1016/0003-9861(80)90293-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  16 in total

1.  Multiple retinoic acid response elements cooperate to enhance the inducibility of CYP26A1 gene expression in liver.

Authors:  Yao Zhang; Reza Zolfaghari; A Catharine Ross
Journal:  Gene       Date:  2010-06-08       Impact factor: 3.688

Review 2.  Clinical pharmacokinetics of tretinoin.

Authors:  M B Regazzi; I Iacona; C Gervasutti; M Lazzarino; S Toma
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

3.  Antitumor activity of DMAKO-05, a novel shikonin derivative, and its metabolism in rat liver microsome.

Authors:  Xu Zhang; Ru-Bing Wang; Wen Zhou; Sui Xiao; Qing-Qing Meng; Shao-Shun Li
Journal:  AAPS PharmSciTech       Date:  2014-10-02       Impact factor: 3.246

Review 4.  Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.

Authors:  Nina Isoherranen; Guo Zhong
Journal:  Pharmacol Ther       Date:  2019-08-13       Impact factor: 12.310

5.  Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases.

Authors:  Ariel R Topletz; Jayne E Thatcher; Alex Zelter; Justin D Lutz; Suzanne Tay; Wendel L Nelson; Nina Isoherranen
Journal:  Biochem Pharmacol       Date:  2011-10-14       Impact factor: 5.858

6.  Arachidonic acid-mediated cooxidation of all-trans-retinoic acid in microsomal fractions from human liver.

Authors:  L Nadin; M Murray
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.

Authors:  Ariel R Topletz; Sasmita Tripathy; Robert S Foti; Jakob A Shimshoni; Wendel L Nelson; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2014-12-09       Impact factor: 4.436

Review 8.  PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia.

Authors:  Kazunori Ohnishi
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

9.  Modulation of all-trans retinoic acid pharmacokinetics by liarozole.

Authors:  V A Miller; J R Rigas; J R Muindi; W P Tong; E Venkatraman; M G Kris; R P Warrell
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  The epithelial differentiating activity in vivo of (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl) -1-propenyl]benzoic acid and 4,4-difluororetinoic acid.

Authors:  D A Miller; A Stephens-Jarnagin; H F DeLuca
Journal:  Biochem J       Date:  1985-04-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.